Papivax Biotech Inc


PapiVax Biotech Inc. (PBI) is a Taiwan-based biopharmaceutical corporation focused on development of novel therapeutic vaccines for human papillomavirus (HPV)-related infectious disease and cancer. PBI has several clinical stage vaccines for heterologous prime-boost as a one-two punch to knockout persistent viral infection or cancer. PBI’s initial targets are 1: treatment of persistent HPV infection and low-grade cervical intraepithelial neoplasia (<CIN2), an unmet medical need with a large market. 2: cervical cancer.







For speaking, sponsorship and exhibition opportunities contact
Tel: +65 6322 2738